Realtime Robotics Named Finalist in Startup Competition
Realtime Robotics, an innovative automation startup incubated at MassRobotics, has been selected from a highly competitive field as a finalist in the Launch Pad Startup Competition to be held at Automate in Chicago. The company, along with six…
PhaseBio Reports Full Results from Phase 1 Clinical Trial
PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) announced today that results from their Phase 1 clinical trial of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, demonstrated that PB2452 provided immediate and sustained reversal of ticagrelor antiplatelet…
PhaseBio Reports Full Results from Phase 1 Clinical Trial
PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) announced today that results from their Phase 1 clinical trial of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, demonstrated that PB2452 provided immediate and sustained reversal of ticagrelor antiplatelet…
Precision Biosciences hoping to raise $100 million through an IPO
DURHAM A biotechnology company based in downtown Durham has filed plans to go public — a move that could net the company around $100 million. Precision BioSciences, which has offices at the historic Venable Center…
Black Sage Selects Echodyne for Security Solutions
3D Radar will Support Systems Integrator in Critical Counter-UAS Applications Echodyne, the manufacturer of innovative, high-performance, small electronically scanned array (ESA) radars for government and commercial markets, announced today that its security radar, EchoGuard, has been…
Kymeta & Airbus in Peru to demonstrate ‘SmartBus’ satellite links
Kymeta Corp., the Redmond, Wash.-based company backed by Microsoft co-founder Bill Gates and other investors, has demonstrated the performance of its flat-panel satellite antennas in an unlikely setting: on top of buses traveling throughout Peru.…
Off-the-shelf CAR-T and gene-editing player Precision Bio files $100M IPO
Precision BioSciences is looking to raise up to $100 million in an IPO just a few months after raising $110 million in a series B and bagging a hepatitis B alliance with Gilead. The Durham, North…
PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452
PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Presentation at the American College of Cardiology’s 68th Annual Scientific Session Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused…
String of ions may out-compute best quantum computers
New ion-based quantum computer debuts by computing the ground state of water. CHRIS LEE – 2/26/2019, 10:19 AM [Originally posted on Ars Technica] Usually, I reflexively delete press releases. This one was no different, but as the…